Bill Allan

Kate joined Vascular Flow Technologies from Braveheart Ventures where she was responsible for the evaluation and development of investment opportunities, focusing on financial diligence.
A Chartered Certified Accountant, she trained with PriceWaterhouseCoopers, qualifying in 2001 and continued in professional practice until joining Braveheart in 2004. Prior to embarking on her professional training Kate held a number of different accounting roles in a variety of industries including manufacturing, wholesale and leisure.

Jim has over 2 decades of experience in the Global Medical Device Business with a special interest in cardiovascular, LVAD, TAH and dialysis disease areas.
He works with numerous large and small device companies assisting in the successful promotion and commercialisation of their novel technologies.
This experience will help guide Vascular Flow through the next stages of their development and global expansion.

As Chair of Clinical Imaging and Intervention, University of Dundee, Professor Houston is a Consultant Cardiovascular Radiologist with an interest in endo-vascular therapies, and non-invasive vascular imaging using MRI and Ultrasound.
His medical training at St. Thomas’s Hospital in London followed first class honours science degrees in physics and pathology at Cambridge University.
His endo-vascular training was undertaken initially in Glasgow and further developed as a Fellow at the University of British Columbia, Vancouver, Canada. He is responsible for intellectual property, and as Medical Director is responsible for the clinical scientific research in the Spiral Laminar Flow™ field and stent technology.

Lucy joined Vascular Flow Technologies in January 2020 bringing with her knowledge and experience in quality and research and development gained in medical device manufacturing. Lucy also has experience in biocompatibility and toxicology as well as working with regulatory agencies e.g US FDA.
Lucy has a BSc in Chemistry from Aberdeen University.